Mojtaba Falahati - Nanotechnology

Author Information

Mojtaba Falahati is affiliated with the Department of Nanotechnology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. His research primarily focuses on nanotechnology applications in medical science, particularly in the areas of cancer treatment, neurotoxicity, and wound healing.

Research Contributions

Mojtaba Falahati has made significant contributions to the field of nanotechnology, with extensive research on metal organic frameworks, nanozymes, and nanoparticles for therapeutic and diagnostic applications. His work encompasses the development of innovative materials for targeted cancer treatment, the promotion of wound healing in diabetic patients, and the investigation of neurotoxicity related to Alzheimer's disease. Notable publications include studies on nitric oxide-releasing biomaterials, enzyme-polymeric/inorganic metal oxide hybrid nanoparticle bio-conjugates, and the regulation of intrinsic apoptosis pathways in cancer cells.

Aliases

Mojtaba Falahati is also known by the name M. Falahati.

Publication and Citation Metrics

Metric	Value
Total Citations	3968
H-index	34
Total Papers	151

Publications:

Explaining chemical clues of metal organic framework-nanozyme nano-/micro-motors in targeted treatment of cancers: benchmarks and challenges

DOI: 10.1186/s12951-022-01375-z

Year: 2022

Nitric oxide-releasing biomaterials for promoting wound healing in impaired diabetic wounds: State of the art and recent trends.

DOI: 10.1016/j.biopha.2022.112707

Year: 2022

Tin oxide nanoparticles trigger the formation of amyloid β oligomers/protofibrils and underlying neurotoxicity as a marker of Alzheimer's diseases.

DOI: 10.1016/j.ijbiomac.2022.01.190

Year: 2022

Copper oxide nanoparticles promote amyloid-β-triggered neurotoxicity through formation of oligomeric species as a prelude to Alzheimer's diseases.

DOI: 10.1016/j.ijbiomac.2022.03.006

Year: 2022

Enzyme–polymeric/inorganic metal oxide/hybrid nanoparticle bio-conjugates in the development of therapeutic and biosensing platforms

DOI: 10.1016/j.jare.2021.01.012

Year: 2021

Evaluation of heptelidic acid as a potential inhibitor for tau aggregation-induced Alzheimer's disease and associated neurotoxicity.

DOI: 10.1016/j.ijbiomac.2021.05.018

Year: 2021

Development of doxorubicin-loaded chitosan–heparin nanoparticles with selective anticancer efficacy against gastric cancer cells in vitro through regulation of intrinsic apoptosis pathway

DOI: 10.1016/j.arabjc.2021.103266

Year: 2021

Thermodynamic and anticancer properties of inorganic zinc oxide nanoparticles synthesized through co-precipitation method

DOI: 10.1016/J.MOLLIQ.2021.115602

Year: 2021

In vivo guiding inorganic nanozymes for biosensing and therapeutic potential in cancer, inflammation and microbial infections.

DOI: 10.1016/j.talanta.2020.121805

Year: 2021

Polymeric micelles functionalized with cell penetrating peptides as potential pH-sensitive platforms in drug delivery for cancer therapy: A review

DOI: 10.1016/J.ARABJC.2021.103264

Year: 2021

What is the Role of Superposition in Nanotechnology?

What are the Future Prospects of nZVI?

What are the Applications of MWCNTs?

Why is Toxicity Testing Important in Nanotechnology?

What is Coordination in Nanotechnology?

How Do Resists Work?

What Applications Can Benefit from TFETs?

What About Hybrid Solar Cells?

What are Carbon Nanotubes and Their Role in Electronics?

What Are Advanced Resists in Nanotechnology?

Partnered Content Networks

Relevant Topics